Interactive Transcript
0:01
I'd like to review one more time the categorization
0:04
of cyan nasal fungal disease since it is such an interesting
0:08
topic and can be confusing.
0:11
So we have different levels of aggressiveness
0:14
to the fungal infection.
0:16
It can just be sapr prophetic growth
0:18
where we may see some hyper density on CT scan.
0:22
In the secretions of the perinasal sinuses,
0:25
we can have a fungus ball, also known as a mycetoma,
0:28
or if it's characterized by the aspergillus fungus,
0:33
an asperger that again, is a benign entity
0:37
with no aggressive features or aggressive invasion.
0:41
We also have the allergic fungal rhinoc sinusitis,
0:45
which is the entity that has multiple involvement
0:48
of the sinuses with expansion and polypoid changes
0:51
and has the eosinophilic mucin.
0:54
Then we shift to the invasive types.
0:56
We talked about the acute invasive fungal sinusitis
0:59
where you may have aggressive destruction of the bone.
1:03
We see that necrotic appearance on post gadolinium
1:06
and hand scans as well as dark on the T two wade scan,
1:10
and it may lead to invasion of the cavernous sinus
1:13
and vascular complications usually seen in patients
1:16
who are immune compromised, especially
1:19
patients in diabetic ketoacidosis.
1:22
And we also have the chronic invasive form
1:25
where it's lasting greater than three months
1:27
and the form that may occur in Southeast Asia as well
1:30
as in Africa.
1:34
So here is a MR study showing a patient
1:39
who has a fungus ball.
1:41
You note that the abnormality is bright on the T one
1:44
weighted scan and dark on the T two weighted scan.
1:47
Very characteristic of fungal infection in general,
1:51
but this could be just
1:53
very hyper protein tenacious secretions.
1:56
The fact that we see it without aggressive
1:59
features without invasion in a opacified
2:03
perinasal sinus, in this case,
2:04
the right maxillary antrum would give us the likely
2:08
diagnosis of an asperger, a mycetoma, a fungus ball,
2:12
all these terms used interchangeably.
2:16
The next entity is the allergic fungal sinusitis.
2:18
And I showed you the article
2:20
by Resh Mukherjee on this topic.
2:22
It's a hypersensitivity reaction
2:25
to fungal antigens in a patient who has a predisposition
2:28
for allergies, asthma, et cetera.
2:31
You have accumulation of the allergic mucin with charco
2:36
laden crystals.
2:38
And this entity is one that is again,
2:41
not an aggressive invasive form.
2:44
The five criteria that we say for allergic fungal signs is
2:48
that it's a type one hypersensitivity reaction associated
2:52
with nasal polyps.
2:53
CT scan showing opacification
2:55
of multiple paranasal sinuses, the
2:59
Presence of eosinophilic mucin
3:00
and positive fungal stain on the surface
3:03
of the secretions without aggressive invasion of the
3:08
submucosal or bone.
3:10
So here is an example of allergic fungal sinusitis
3:13
where you see that there's expansion
3:15
of the perinasal sinuses with hyperdense secretions.
3:19
There is some thinning of the bone.
3:22
You may see that this bone loss is present,
3:25
but this is still confined by the periosteum
3:28
and is not aggressively invading the orbits.
3:31
But you could see that expansion in sort
3:33
of a polypoid fashion
3:36
with the hyperdense secretions involving multiple
3:39
of the paranasal sinuses.
3:41
Another example of same hyperdense,
3:44
this is a non-contrast CT scan.
3:47
Hyperdense secretions growing into the nasal cavity
3:50
with a poid change identified by the expansion
3:53
of the airway of the sinus or of the nasal airway
3:59
and this absence of invasion of the adjacent tissue
4:04
allergic fungal sinusitis.
4:07
And then finally, we have the aggressive invasive sinusitis.
4:11
And I wanna date myself if I may.
4:14
This is a report from 1989.
4:18
First author used some about MR findings in Rhino Cerebral
4:23
Mucor Mycosis.
4:24
This is was a study in which you can see
4:27
that there was aggressive invasion of the cavernous sinus.
4:32
On the left side here is a post gadolinium scan in which
4:37
the normal right cavernous sinus enhances.
4:41
But as you can see, the left cavernous
4:43
sinus is not enhancing.
4:44
That's abnormal. And
4:46
that implies cavernous sinus thrombosis.
4:49
And you notice that the lumen of the
4:52
left internal carotid artery is much decreased compared
4:56
to the lumen of the right internal carotid artery
4:59
identifying the vasculitis.
5:01
And this patient, as you can see, went on
5:03
to a stroke involving the left middle cerebral artery
5:07
distribution, seen both on the MRI scan as well
5:11
as ultimately on the CT scan.
5:14
You can also see the aggressive invasion of the orbit.
5:16
So this is aggressive invasive
5:20
fungal sinusitis if it lasts greater than three months
5:23
and continues,
5:25
we're going call it the chronic invasive form.
5:29
So some of you trainees out there probably were not even
5:32
born at the time that this article was published.
5:36
Another example of acute invasive fungal sinusitis.
5:40
Now this is typically seen in the inpatient setting
5:43
where we have a patient who has a fever and maybe leukemia
5:47
or is own chemotherapeutic drugs and they ask whether
5:50
or not there is aggressive invasive sinusitis.
5:53
And what one sees with the arrows here is the infiltration
5:57
Of the perianal fat.
5:58
On the right side, there is some soft tissue swelling also
6:01
anterior to this maxillary sinus.
6:04
Doesn't look all that bad,
6:06
but there is erosion of the medial wall
6:08
of this maxillary sinus.
6:10
And here you can see the invasion of the orbit
6:12
with inflammatory conditions here.
6:15
And ultimately this pattern that you see of the absence
6:19
of enhancement of the traditional mucosa
6:22
of the sinus leading to spread intracranial
6:25
with bright signal intensity on the diffusion wave scan,
6:30
identifying infarcted tissue.
6:32
So always look at the perianal fat on your CT scan in a
6:37
patient who's immune compromised to see whether you have
6:40
invasive fungal sinusitis as a potential complication of
6:44
that primary lymphoma leukemia
6:47
or patient on immunosuppressive drugs.